Allele Biotechnology Partners with CIRM to Accelerate Regenerative Medicine Product Development in California
Allele will provide CIRM grantees with priority access to Allele’s mRNA reprogrammed cGMP iPSC lines, mRNA technologies for reprogramming, differentiation, gene editing, and end-to-end cell therapy CDMO services. Allele Biotechnology & Pharmaceuticals Inc. (ALLELE), a San Diego, CA, based biopharma and California Institute for Regenerative Medicine (CIRM) has signed a Memorandum of Understanding by…